We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

From advanced imaging to AI-driven analysis, we seek studies that not only push the boundaries of what is possible but also directly address the clinical needs of conditions such as ALS, Autism, ...

“If you go back 20 years, there was quite a negative health picture attached to coffee,” notes Paul Rooke, executive director ...

The Covenant Cafe, an early stage Alzheimer’s activity group, will be held on Tuesday, Nov. 19, from 1-3 p.m., at Covenant United Methodist Church, 44 W. Main St., Lock Haven. David Bellomo, Community ...

NIDUS-Family is a training and support intervention for home care workers caring for people living with dementia in their own ...

Grand Island couple shares experience with disease ...

A new nasal spray therapy by Texas A&M researchers shows promise in delaying Alzheimer’s progression by targeting brain ...

Diabetes is a growing global health concern. It often shows no early symptoms, leading to delayed diagnosis and potential ...

As people age, the body changes as part of the normal ageing process, such as greying hair and loss of elasticity in the skin ...

The "Caring for the Caregiver" resource fair is designed to provide assistance and support for individuals facing challenges such as memory problems.

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.